George M. Jenkins

George M. Jenkins discloses dealings in Palvella Therapeutics, Inc. to SEC (Form 4). We count 31 filings; the first trade dates from 18 December 2024 and the latest from 14 October 2026.

The open-market side counts 5 purchases for €609k alongside 26 sales for €6.8M. Sales outweigh purchases by €6.2M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2026: 2 purchases and 26 sales on the market.

Half of the purchases are above €46k and half below. Of 5 purchases, 1 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. After 3 purchases with a full 90-day history, the hit rate stands at 67% and the median 90-day move at +12.0%. These figures describe past trades and do not predict future prices.

The newest entry dates from 14 October 2026: an open-market sale of €602k, in Palvella Therapeutics, Inc. The clock since the last published purchase (1 April 2026) now reads 206 days. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.